Breaking News

Fujifilm Launches Fujifilm Diosynth Biotechnologies

The former Merck BioManufacturing Network has been named Fujifilm Diosynth Biotechnologies following the completion of FUJIFILM Corp.’s recent acquisition of the company.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The former Merck BioManufacturing Network has been named Fujifilm Diosynth Biotechnologies following the completion of FUJIFILM Corp.’s recent acquisition of the company. The acquisition includes the facilities located in Billingham, UK (MSD Biologics Ltd., formerly Avecia Biologics) and Research Triangle Park, NC (Diosynth RTP LLC). Yuzo Toda, general manager of Pharmaceutical Products Division, FUJIFILM Corp., said, “We are delighted to complete the addition of this business to Fujifilm’s g...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters